Neil R. Ackerman

Neil R. Ackerman

No más puestos en curso

Fortuna: 4 M $ al 31/05/2024

81 años
Health Technology
Consumer Services
Finance

Perfil

Dr. Ackerman served in a variety of management positions at Cygnus, Inc from 1994-2005.
He initially led the development efforts for a number of transdermal products, two of which were approved.
He then led the R&D, clinical, regulatory and compliance functions for the Glucowatch Biographer, the first commercially available non-invasive glucose monitor.
From 1990-1994 he was Vice President, Research and Development at Glycomed, leading its discovery efforts in cardiovascular and inflammatory diseases.
From 1982-1990, he was Research Director, Cancer and Inflammatory Diseases with DuPont Pharmaceuticals.
Prior to that time, he had research and management positions at Syntex Corporation and Pfizer, Inc. He is currently an advisor to MMV Financial.
Dr. Ackerman received his Ph.D.
degree from the University of Maryland, and completed a post-doctoral fellowship in immunology at Stanford University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
05/05/2023 62 378 ( 0.01% ) 4 M $ 31/05/2024

Antiguos cargos conocidos de Neil R. Ackerman.

EmpresasCargoFin
Director Técnico/Científico/I+D 01/04/2005
Corporate Officer/Principal -
Ver el detalle de la experiencia de Neil R. Ackerman.

Formación de Neil R. Ackerman.

University of Maryland Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Neil R. Ackerman.

Relaciones

14

Relaciones de 1er grado

3

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas2

Health Technology

Finance

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Neil R. Ackerman